14 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

BISFIL-M(LIGHT CURABLE ANTERIOR COMPOSITE)

FDA 510(k)
FDA Class 2 ·Dental

APEX CR Knee

FDA UDI
Omni Life Science, Inc.·00841690111726·Retaining Bolt Congruent or Ultra, Modular Tibi...

LEONE SPA

FDA UDI
LEONE SPA·08033707030812·WEB 1ST MOL BANDS W/G8325-03 UL 1

Legacy™ Cover Screw

FDA UDI
IMPLANT DIRECT SYBRON MANUFACTURING LLC·10841307111009·

NAR

FDA UDI
NORTH AMERICAN RESCUE, LLC·00842209107223·

Integrated Spine System

FDA UDI
Ortho Development Corporation·00822409030972·Diameter 8.5 x 30 mm Pedicle Screw

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523121151·8.5mm Tap Cannulated

LEECO TESTO-QUANT DIAGNOSTIC KIT

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

KT Airway Clearance Device II (KT-3); KT Airway Clearance Device II (KT-5)

FDA 510(k)
FDA Class 2 ·Anesthesiology

APEX KNEE SYSTEM

FDA Adverse Event
Injury ·OMNILIFE SCIENCE INC.·Product code JWH·March 3, 2023

ACCU-CHEK ® TENDER INFUSION SET

FDA Adverse Event
Malfunction ·ROCHE DIAGNOSTICS·Product code FPA·June 6, 2014

ACCU-CHEK ® AVIVA TEST STRIPS

FDA Adverse Event
Malfunction ·ROCHE DIAGNOSTICS·Product code LFR·October 5, 2010

OBTRYX SYSTEM

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC - MARLBOROUGH·Product code FTL·November 30, 2012

Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.

FDA Enforcement
Class II ·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012